Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Rifaximin Therapy in Patients Pre-Diagnosed With Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo Controlled Study

NCT02009618 is registered in ClinicalTrials.gov with Bezmialem Vakif University as lead sponsor.

NCT NCT02009618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02009618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Rifaximin Therapy in Patients Pre-Diagnosed With Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo Controlled Study
Lead sponsor
Bezmialem Vakif University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
October 31, 2013
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibs